Feasibility Study of Treating Tricuspid Regurgitation With K-ClipTM Transcatheter Annuloplasty System - Trial NCT05434507
Access comprehensive clinical trial information for NCT05434507 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Huihe Medical Technology Co., Ltd and is currently Recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 10 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Shanghai Huihe Medical Technology Co., Ltd
Timeline & Enrollment
N/A
Sep 16, 2021
Sep 16, 2026
Primary Outcome
Success rate 1year after operation,Success rate of operation,Success rate of device implantation,Change in echocardiographic parameters,Change in echocardiographic parameters,Change of Tricuspid Regurgitation Grade,NYHA Functional Class,6 minutes walk distance,Kansas City Cardiomyopathy Questionnaire
Summary
Evaluate the effectiveness and safety of the transcatheter tricuspid annuloplasty system
 manufactured by Shanghai Huihe Medical Technology Co., Ltd. for the treatment of patients
 with moderate-severe or worse tricuspid regurgitation
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05434507
Device Trial